SCINAI IMMUNOTHERAPEUTICS LTD

NASDAQ: SCNI (Scinai Immunotherapeutics Ltd.)

Last update: 2 days ago, 2:08PM

1.66

-0.01 (-0.60%)

Previous Close 1.67
Volume 3,493,695
Price / Sales 0.600
Price / Book 0.190
52 Weeks Range
1.60 (-3%) — 16.40 (887%)
Profit Margin 728.88%
Operating Margin (TTM) -1,098.54%
Quarterly Earnings Growth (YOY) 236.50%
Total Debt/Equity (MRQ) 20.91%
Current Ratio (MRQ) 1.32
Operating Cash Flow (TTM) -6.33 M
Levered Free Cash Flow (TTM) -3.82 M
Return on Assets (TTM) -34.92%
Return on Equity (TTM) 177.37%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock Scinai Immunotherapeutics Ltd. - -

AIStockmoo Score

-0.8
Analyst Consensus NA
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average -0.81

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SCNI - - - 0.190
HLVX 103 M - - 0.710
IPA 96 M - - 5.98
ALVR 48 M - - 0.430
SONN 33 M - - 2.07
UPB - - - 1.16

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 18.22%
% Held by Institutions 26.55%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria